AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 26-50/56

Authors: Ioannidis, JPA Havlir, DV Tebas, P Hirsch, MS Collier, AC Richman, DD
Citation: Jpa. Ioannidis et al., Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication, AIDS, 14(11), 2000, pp. 1481-1488

Authors: Precious, HM Gunthard, HF Wong, JK D'Aquila, RT Johnson, VA Kuritzkes, DR Richman, DD Brown, AJL
Citation: Hm. Precious et al., Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy, AIDS, 14(1), 2000, pp. 31-36

Authors: Hirsch, MS Richman, DD
Citation: Ms. Hirsch et Dd. Richman, The role of genotypic resistance testing in selecting therapy for HIV - Reply, J AM MED A, 284(13), 2000, pp. 1650-1650

Authors: Carpenter, CCJ Cooper, DA Fischl, MA Gatell, JM Gazzard, BG Hammer, SM Hirsch, MS Jacobsen, DM Katzenstein, DA Montaner, JSG Richman, DD Saag, MS Schechter, M Schooley, RT Vella, S Yeni, PG Volberding, PA
Citation: Ccj. Carpenter et al., Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel, J AM MED A, 283(3), 2000, pp. 381-390

Authors: Havlir, DV Hellmann, NS Petropoulos, CJ Whitcomb, JM Collier, AC Hirsch, MS Tebas, P Sommadossi, JP Richman, DD
Citation: Dv. Havlir et al., Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens, J AM MED A, 283(2), 2000, pp. 229-234

Authors: Hirsch, MS Brun-Vezinet, F D'Aquila, RT Hammer, SM Johnson, VA Kuritzkes, DR Loveday, C Mellors, JW Clotet, B Conway, B Demeter, LM Vella, S Jacobsen, DM Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426

Authors: Hanna, GJ Johnson, VA Kuritzkes, DR Richman, DD Martinez-Picado, J Sutton, L Hazelwood, JD D'Aquila, RT
Citation: Gj. Hanna et al., Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase, J CLIN MICR, 38(7), 2000, pp. 2715-2721

Authors: Martinez-Picado, J DePasquale, MP Kartsonis, N Hanna, GJ Wong, J Finzi, D Rosenberg, E Gunthard, HF Sutton, L Savara, A Petropoulos, CJ Hellmann, N Walker, BD Richman, DD Siliciano, R D'Aquila, RT
Citation: J. Martinez-picado et al., Antiretroviral resistance during successful therapy of HIV type 1 infection, P NAS US, 97(20), 2000, pp. 10948-10953

Authors: Brown, AJL Precious, HM Whitcomb, JM Wong, JK Quigg, M Huang, W Daar, ES D'Aquila, RT Keiser, PH Connick, E Hellmann, NS Petropoulos, CJ Richman, DD Little, SJ
Citation: Ajl. Brown et al., Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites, J VIROLOGY, 74(22), 2000, pp. 10269-10273

Authors: Havlir, DV Tierney, C Friedland, GH Pollard, RB Smeaton, L Sommadossi, JP Fox, L Kessler, H Fife, KH Richman, DD
Citation: Dv. Havlir et al., In vivo antagonism with zidovudine plus stavudine combination therapy, J INFEC DIS, 182(1), 2000, pp. 321-325

Authors: Hanna, GJ Johnson, VA Kuritzkes, DR Richman, DD Brown, AJL Savara, AV Hazelwood, JD D'Aquila, RT
Citation: Gj. Hanna et al., Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine, J INFEC DIS, 181(3), 2000, pp. 904-911

Authors: Gunthard, HF Wong, JK Spina, CA Ignacio, G Kwok, S Christopherson, C Hwang, J Haubrich, R Havlir, D Richman, DD
Citation: Hf. Gunthard et al., Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy, J INFEC DIS, 181(2), 2000, pp. 522-531

Authors: Appay, V Nixon, DF Donahoe, SM Gillespie, GMA Dong, T King, A Ogg, GS Spiegel, HML Conlon, C Spina, CA Havlir, DV Richman, DD Waters, A Easterbrook, P McMichael, AJ Rowland-Jones, SL
Citation: V. Appay et al., HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function, J EXP MED, 192(1), 2000, pp. 63-75

Authors: Spina, CA Prince, HE Richman, DD
Citation: Ca. Spina et al., Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro (vol 99, pg 1774, 1997), J CLIN INV, 106(12), 2000, pp. 1571-1571

Authors: Richman, DD
Citation: Dd. Richman, Normal physiology and HIV pathophysiology of human T-cell dynamics, J CLIN INV, 105(5), 2000, pp. 565-566

Authors: Tighe, H Takabayashi, K Schwartz, D Marsden, R Beck, L Corbeil, J Richman, DD Eiden, JJ Spiegelberg, HL Raz, E
Citation: H. Tighe et al., Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity, EUR J IMMUN, 30(7), 2000, pp. 1939-1947

Authors: Gulick, RM Mellors, JW Havlir, D Eron, JJ Meibohm, A Condra, JH Valentine, FT McMahon, D Gonzalez, C Jonas, L Emini, EA Chodakewitz, JA Isaacs, R Richman, DD
Citation: Rm. Gulick et al., 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine, ANN INT MED, 133(1), 2000, pp. 35-39

Authors: Lange, JMA Richman, DD
Citation: Jma. Lange et Dd. Richman, Retroviruses & opportunistic infections '99, ANTIVIR TH, 4(1), 1999, pp. 5-6

Authors: Richman, DD
Citation: Dd. Richman, Hot papers - HIV - Recovery of replication-competent HIV despite prolongedsuppression of plasma viremia by J.K. Wong, M. Hezareh, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, C.A. Spina, D.D. Richman - Comments, SCIENTIST, 13(24), 1999, pp. 22-22

Authors: Vazquez-Rosales, G Lerma, JGG Yamamoto, S Switzer, WM Havlir, D Folks, TM Richman, DD Heneine, W
Citation: G. Vazquez-rosales et al., Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma, AIDS RES H, 15(13), 1999, pp. 1191-1200

Authors: Ruiz, L van Lunzen, J Arno, A Stellbrink, HJ Schneider, C Rull, M Castella, E Ojanguren, I Richman, DD Clotet, B Tenner-Racz, K
Citation: L. Ruiz et al., Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue, AIDS, 13(1), 1999, pp. F1-F8

Authors: Little, SJ Daar, ES D'Aquila, RT Keiser, PH Connick, E Whitcomb, JM Hellmann, NS Petropoulos, CJ Sutton, L Pitt, JA Rosenberg, ES Koup, RA Walker, BD Richman, DD
Citation: Sj. Little et al., Reduced antiretroviral drug susceptibility among patients with primary HIVinfection, J AM MED A, 282(12), 1999, pp. 1142-1149

Authors: Craig, HM Pandori, MW Riggs, NL Richman, DD Guatelli, JC
Citation: Hm. Craig et al., Analysis of the SH3-Binding region of HIV-1 Nef: Partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket, VIROLOGY, 262(1), 1999, pp. 55-63

Authors: Gunthard, HF Leigh-Brown, AJ D'Aquila, RT Johnson, VA Kurizkes, DR Richman, DD Wong, JK
Citation: Hf. Gunthard et al., Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol (vol 259, pg 154, 1999), VIROLOGY, 261(2), 1999, pp. 367-367

Authors: Gunthard, HF Leigh-Brown, AJ D'Aquila, RT Johnson, VA Kuritzkes, DR Richman, DD Wong, JK
Citation: Hf. Gunthard et al., Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol, VIROLOGY, 259(1), 1999, pp. 154-165
Risultati: 1-25 | 26-50 | 51-56